断端癌の英語

既知のＩ型コラーゲンのＣ端非３重鎖テロペプチド（ＩＣＴＰ）を、結腸癌、直腸、子宮頚癌、子宮体癌、胃癌、食道癌の適切な診断マーカーとして用いる。例文帳に追加

Carboxy terminal telopeptide of type I collagen (ICTP) of a known I-type collagen is used as the diagnostic marker suitable for cancer of the colon, the rectum, the cancer of the cervix, cancer of corpus uteri, gastic cancer and cancer of the esophagus. - 特許庁

分泌型GPC3のＮ端を認識する抗GPC3抗体による、被検試料中の可溶化GPC3のin vitroにおける検出、および、被検体が癌、特に肝臓癌に罹患しているか否かの診断。例文帳に追加

The method comprises detecting in vitro a solubilized GPC3 in a test sample by an anti-GPC3 antibody recognizing the N-terminal of a secreted form of GPC3 and diagnosing whether a subject suffers from cancer, in particular hepatoma. - 特許庁

既知のＩ型コラーゲンのＣ端非３重鎖テロペプチド（ＩＣＴＰ）を、進行胃癌、特にスキルス胃癌の適切な診断マーカーとして用いる。例文帳に追加

In this early diagnostic method, the C-terminus non-triple chain telopeptide (ICTP) of known type I collagen is used as a proper diagnostic marker for progressive stomach cancer, especially for scirrhus stomach cancer. - 特許庁

TGR23-2リガンドのN端側またはC末端の部分ペプチドに特異的に反応する抗体、および該抗体を用いたTGR23-2リガンドの検出・定量法、およびこれらを用いた癌の予防・治療剤および診断薬等。例文帳に追加

Provided are an antibody to specifically react to a partial peptide at an N terminal or C terminal of the TGR23-2 ligand, the method for detecting and quantitatively determining the TGR23-2 using the antibody, and a preventing/treating agent for cancer, the diagnostic agent, or the like, using these. - 特許庁

先端ＣＣＤ型蛍光内視鏡を用いて、混合状態で取得された蛍光画像から各蛍光薬剤毎の蛍光の分布画像を取得することを可能とし、癌細胞の診断能を向上する。例文帳に追加

To improve the ability to diagnose a cancer cell by permitting the distribution image of fluorescence to be acquired for every fluorescent medicine from fluorescence images acquired in a mixture condition by using a tip CCD type fluorescence endoscope. - 特許庁

ＢＳＤＬおよび／またはＦＡＰＰの組換えならびに／あるいは天然のＣ−末端糖ペプチドを認識するモノクローナル抗体、ならびに糖尿病および膵外分泌部の癌の治療もしくは予防プロトコルにおける診断方法の提供。例文帳に追加

To provide a monoclonal antibody recognizing the recombinant and/or natural C-terminal glycopeptides of BSDL and/or FAPP, and a diagnostic method in therapeutic or preventive protocols of diabetes and cancer of the exocrine pancreas. - 特許庁

術者自身が内視鏡的粘膜切除術（ＥＭＲ）中に切除断端を判定でき、陽性の恐れがある場合、どこを追加切除すればよいのかが分かり、すぐその場で追加切除して癌の取り残しを減らす。例文帳に追加

To allow an operator himself to judge an excised end during endoscopic mucosal resection(EMR), so that a part to be additionally excised can be easily found when there is a danger that the result is positive, and imme diately additionally cut on the spot to reduce an insufficient excision of cancer. - 特許庁